+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Antibiotics & Antimicrobials Market - Global Forecast 2026-2032- Product Image
Animal Antibiotics & Antimicrobials Market - Global Forecast 2026-2032- Product Image
Sale

Animal Antibiotics & Antimicrobials Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4995354
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Animal Antibiotics & Antimicrobials Market is projected to reach USD 4.87 Billion in 2026. It is expected to continue growing at a CAGR of 7.08%, reaching USD 7.41 Billion by 2032.

Animal antibiotics and antimicrobials remain essential to veterinary medicine, food-animal productivity, and companion-animal health, but their role is being redefined by antimicrobial resistance, tighter stewardship expectations, and changing consumer demand for responsibly produced protein. The market spans medically important antibiotics, ionophores, sulfonamides, tetracyclines, macrolides, beta-lactams, fluoroquinolones, and other veterinary antimicrobial classes used under regulated conditions to treat, control, and prevent bacterial disease in livestock, poultry, aquaculture, and pets.

The sector is now shaped by a clear public-health mandate: preserve antimicrobial effectiveness while sustaining animal welfare and food security. WHO identifies antimicrobial resistance as one of the top global public-health threats, while WOAH, FAO, and national regulators continue to promote surveillance, veterinary oversight, responsible prescribing, and prudent-use frameworks. As a result, growth opportunities are increasingly tied to prescription-based access, diagnostics-led treatment, residue compliance, farm biosecurity, and alternatives that reduce disease pressure without undermining therapeutic availability.

Transformative Shifts in the Animal Antimicrobials Landscape

The animal antimicrobials landscape is shifting from volume-led medication toward evidence-based, need-specific therapy. In the United States, FDA policy removed production uses of medically important antimicrobials from feed and water labels and brought remaining therapeutic uses under veterinary oversight. In the European Union, legislation prohibits antibiotic growth promotion and restricts routine prophylaxis, reinforcing a market direction centered on accountable prescribing and farm-level prevention.

At the same time, producers face persistent disease risks from intensive farming, climate-linked pathogen pressure, cross-border animal movement, and expanding aquaculture. These conditions are accelerating demand for rapid diagnostics, vaccination programs, precision dosing, traceability systems, and integrated herd-health services. Suppliers that combine compliant antimicrobial portfolios with stewardship support, residue management, and outcome-based veterinary guidance are better positioned than those relying on undifferentiated product access.

Cumulative Impact of Artificial Intelligence on Veterinary Antimicrobials

Artificial intelligence is becoming a practical enabler of antimicrobial stewardship rather than a replacement for veterinary judgment. AI-supported disease surveillance can combine farm records, production data, environmental signals, laboratory results, and treatment history to detect abnormal morbidity patterns earlier. This helps veterinarians target testing, isolate affected groups, and reduce unnecessary blanket treatment.

AI is also improving antimicrobial decision support through predictive analytics, resistance-pattern monitoring, image-based diagnostics, and optimization of dosage and withdrawal-period compliance. In research and development, machine learning is used to screen antimicrobial candidates, evaluate combinations, and identify resistance markers. The most immediate commercial value lies in AI-enabled precision livestock management: fewer treatment failures, better documentation, stronger audit readiness, and more defensible antibiotic use across complex supply chains.

Key Regional Insights for Animal Antibiotics & Antimicrobials

Asia-Pacific is a high-priority region because it combines large livestock populations, fast-growing poultry and aquaculture industries, and increasing regulatory attention to antimicrobial resistance. China, India, Japan, South Korea, and Australia are advancing surveillance, veterinary oversight, and residue-control systems at different speeds, creating demand for compliant animal antibiotics, veterinary antimicrobials, diagnostics, and farm-management tools that support responsible use.

North America is defined by mature veterinary distribution, strong food-safety enforcement, and established prescription oversight. The United States and Canada continue to emphasize medically important antimicrobial stewardship, while Mexico remains important for integrated North American protein supply chains. Latin America, led by Brazil and Mexico, balances export-driven residue compliance with high disease-management needs in cattle, poultry, and swine, making biosecurity, therapeutic reliability, and regulatory documentation central to market participation.

Europe is among the strictest regulatory environments, with EU rules shaping reduced routine use, stronger monitoring, and preference for prevention-led animal health. The Middle East is investing in food security, dairy, poultry, and camel health, while GCC countries are strengthening import standards and veterinary infrastructure. Africa presents long-term potential due to herd expansion and food-security needs, but market development depends on veterinary access, cold-chain reliability, diagnostics capacity, residue monitoring, and control of informal antimicrobial channels.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are increasingly important for poultry, swine, and aquaculture health as governments modernize veterinary regulation and food-safety systems. The region’s opportunity is tied to practical stewardship models that work across smallholders, integrators, and export-oriented producers. BRICS countries represent a major share of global animal protein production and demand, with Brazil, China, India, and Russia requiring scalable disease-control strategies that align productivity with antimicrobial resistance mitigation.

The European Union remains a benchmark for antimicrobial governance through harmonized restrictions, surveillance, and farm-to-fork policy alignment. G7 countries influence global standards through advanced research, pharmaceutical regulation, One Health antimicrobial resistance action plans, and veterinary innovation, while NATO members overlap with many high-income markets where supply-chain resilience, biosecurity, and food-system security have gained strategic importance. GCC markets are smaller in livestock volume than Asia-Pacific or Latin America, but they are strategically relevant because of food-security investment, premium dairy and poultry operations, import dependence, and rising expectations for regulated veterinary care.

Key Country Insights for Animal Antibiotics & Antimicrobials

The United States leads in veterinary oversight, companion-animal care, and regulated livestock antimicrobial use, with FDA stewardship policies shaping market access. Canada follows a similar prudent-use direction, while Mexico’s role in North American beef, pork, and poultry trade makes residue compliance and disease control central. Brazil is one of the world’s most influential animal-protein exporters, making veterinary antimicrobials, biosecurity, and compliance systems critical to poultry, beef, and swine competitiveness.

In Europe, the United Kingdom, Germany, France, Italy, and Spain operate under mature veterinary frameworks with strong attention to antimicrobial reduction, monitoring, and prevention. Germany and France emphasize high-standard veterinary medicine and livestock productivity, while Spain and Italy remain significant livestock and companion-animal markets. Russia has substantial poultry, swine, and cattle production needs, with domestic supply resilience, veterinary access, and disease surveillance influencing market behavior.

China and India are pivotal because of scale, livestock diversity, and rising demand for safe animal protein. China continues to strengthen veterinary regulation and food-safety enforcement, while India’s dairy, poultry, and aquaculture sectors require accessible veterinary solutions and responsible-use education. Japan and South Korea are advanced, quality-focused markets with strong regulatory expectations and sophisticated livestock and companion-animal care systems. Australia combines export-oriented livestock production with strict biosecurity and residue standards, supporting demand for compliant therapeutics and antimicrobial stewardship tools.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize portfolios that align with veterinary oversight, resistance-risk management, and documented therapeutic need. This includes investing in narrow-spectrum options where appropriate, improving label clarity, strengthening pharmacovigilance, and supporting veterinarians with susceptibility testing, treatment protocols, and digital recordkeeping.

Organizations should also build growth beyond the molecule by integrating diagnostics, vaccines, biosecurity advisory services, microbiome-support solutions, and precision-farming platforms. Market access teams need region-specific compliance strategies, especially for EU restrictions, FDA requirements, export residue standards, and emerging-market stewardship programs. Partnerships with laboratories, producer groups, universities, and regulators can improve evidence generation and reinforce trust with retailers, food companies, veterinarians, producers, and consumers.

Research Methodology

The research approach is grounded in a comprehensive framework that leverages verified public-health, veterinary, regulatory, and trade sources. Core references include guidance and surveillance frameworks from the World Health Organization, the World Organisation for Animal Health, the Food and Agriculture Organization, national veterinary authorities, the U.S. Food and Drug Administration, the European Medicines Agency, and regional antimicrobial resistance action plans.

The analysis triangulates regulatory developments, animal-production trends, antimicrobial stewardship policies, veterinary distribution dynamics, food-safety requirements, residue-control expectations, and disease-management needs across regions and countries. Insights are evaluated for commercial relevance, policy consistency, and applicability to animal antibiotics and antimicrobials, with an emphasis on evidence-backed themes rather than unsupported market-size, market-share, or forecasting claims.

Conclusion

The animal antibiotics and antimicrobials market is entering a more disciplined phase in which growth depends on responsible access, measurable outcomes, and alignment with global antimicrobial resistance priorities. Therapeutic antimicrobials will remain indispensable for animal welfare and food security, but their use will be increasingly guided by diagnostics, surveillance, veterinary authorization, and prevention-first herd-health strategies.

Manufacturers, distributors, veterinarians, and producers that embrace stewardship as a commercial advantage can strengthen market resilience. The strongest opportunities will come from compliant antimicrobial portfolios, AI-enabled decision support, regional regulatory expertise, and integrated solutions that reduce disease burden while preserving the effectiveness of critical veterinary medicines.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Animal Antibiotics & Antimicrobials Market, by Class
7.1. Introduction
7.2. Aminoglycosides
7.2.1. Gentamicin
7.2.2. Neomycin
7.2.3. Streptomycin
7.3. Beta Lactams
7.3.1. Cephalosporins
7.3.2. Penicillins
7.4. Fluoroquinolones
7.4.1. Ciprofloxacin
7.4.2. Enrofloxacin
7.4.3. Marbofloxacin
7.5. Macrolides
7.5.1. Erythromycin
7.5.2. Spiramycin
7.5.3. Tilmicosin
7.5.4. Tylosin
7.6. Sulfonamides
7.6.1. Sulfadimethoxine
7.6.2. Sulfamethazine
7.7. Tetracyclines
7.7.1. Chlortetracycline
7.7.2. Doxycycline
7.7.3. Oxytetracycline
7.7.4. Tetracycline
8. Animal Antibiotics & Antimicrobials Market, by Animal Species
8.1. Introduction
8.2. Aquaculture
8.3. Cattle
8.4. Companion Animals
8.5. Poultry
8.6. Swine
9. Animal Antibiotics & Antimicrobials Market, by Administration Route
9.1. Introduction
9.2. Feed Additives
9.3. In Ovo
9.4. Injectable
9.5. Oral
9.6. Topical
9.7. Water Soluble
10. Animal Antibiotics & Antimicrobials Market, by Formulation
10.1. Introduction
10.2. Bolus
10.3. Liquid
10.4. Powder
10.5. Premix
11. Animal Antibiotics & Antimicrobials Market, by End User
11.1. Introduction
11.2. Commercial Farms
11.3. Veterinary Hospitals & Clinics
11.4. Research Institutions
12. Animal Antibiotics & Antimicrobials Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.3. Online
13. Animal Antibiotics & Antimicrobials Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Animal Antibiotics & Antimicrobials Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Animal Antibiotics & Antimicrobials Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. AdvaCare Pharma LLP
17.2. Ashish Life Science Private Limited
17.3. Bayer AG
17.4. Bimeda Holdings Limited
17.5. Boehringer Ingelheim International GmbH
17.6. Ceva Santé Animale S.A.
17.7. China Animal Husbandry Industry Co., Ltd
17.8. Dechra Pharmaceuticals PLC
17.9. ECO Animal Health Group Plc
17.10. Elanco Animal Health Incorporated
17.11. Endovac Animal Health
17.12. Hester Biosciences Limited
17.13. HIPRA S.A.
17.14. Huvepharma EOOD
17.15. Indian Immunologicals Ltd
17.16. Inovet Group
17.17. Intas Animal Health
17.18. Kyoritsu Seiyaku Corporation
17.19. Lutim Pharma Pvt Ltd
17.20. Meiji Holdings Co., Ltd
17.21. Merck & Co., Inc
17.22. Norbrook Laboratories Limited
17.23. Ouro Fino Saúde Animal
17.24. Phibro Animal Health Corporation
17.25. SeQuent Scientific Ltd
17.26. Vetoquinol S.A.
17.27. Vetsfarma Ltd
17.28. Virbac S.A.
17.29. Zoetis Inc
17.30. Zydus Animal Health And Investments Limited
List of Figures
FIGURE 1. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL GENTAMICIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL GENTAMICIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL GENTAMICIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL NEOMYCIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL NEOMYCIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL NEOMYCIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL STREPTOMYCIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL STREPTOMYCIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL STREPTOMYCIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL BETA LACTAMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL BETA LACTAMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL BETA LACTAMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CEPHALOSPORINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CEPHALOSPORINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CEPHALOSPORINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL PENICILLINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL PENICILLINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL PENICILLINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CIPROFLOXACIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CIPROFLOXACIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CIPROFLOXACIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ENROFLOXACIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ENROFLOXACIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ENROFLOXACIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL MARBOFLOXACIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL MARBOFLOXACIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL MARBOFLOXACIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL MACROLIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL MACROLIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL MACROLIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL ERYTHROMYCIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL ERYTHROMYCIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ERYTHROMYCIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SPIRAMYCIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL SPIRAMYCIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL SPIRAMYCIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL TILMICOSIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL TILMICOSIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL TILMICOSIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL TYLOSIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL TYLOSIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL TYLOSIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL SULFONAMIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL SULFONAMIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL SULFONAMIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SULFADIMETHOXINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SULFADIMETHOXINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL SULFADIMETHOXINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL SULFAMETHAZINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL SULFAMETHAZINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL SULFAMETHAZINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL TETRACYCLINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL TETRACYCLINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL TETRACYCLINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL CHLORTETRACYCLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CHLORTETRACYCLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL CHLORTETRACYCLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL DOXYCYCLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL DOXYCYCLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL DOXYCYCLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL OXYTETRACYCLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL OXYTETRACYCLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL OXYTETRACYCLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL TETRACYCLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL TETRACYCLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL TETRACYCLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL POULTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL FEED ADDITIVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL FEED ADDITIVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL FEED ADDITIVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL IN OVO MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL IN OVO MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL IN OVO MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL WATER SOLUBLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL WATER SOLUBLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL WATER SOLUBLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL BOLUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL BOLUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL BOLUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL LIQUID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL POWDER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL POWDER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL POWDER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL PREMIX MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL PREMIX MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL PREMIX MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL COMMERCIAL FARMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL COMMERCIAL FARMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL COMMERCIAL FARMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 155. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 156. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 158. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 159. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 166. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 168. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 169. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 170. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 171. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 172. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 174. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 176. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 181. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 182. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 183. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 184. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 185. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 186. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 187. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 188. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 189. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 190. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 191. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 192. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 193. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 207. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 208. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 209. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 210. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 211. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 212. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 213. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 214. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 215. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 216. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 217. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 218. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 219. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 220. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 221. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 222. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 223. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 224. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 225. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 226. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 227. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 228. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 229. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 230. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 231. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 232. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 233. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 234. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 235. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 236. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 237. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 238. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 239. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 240. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 241. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 242. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 243. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 244. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 245. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 260. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 261. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 262. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 263. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 264. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 265. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 266. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 267. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 268. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 269. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 270. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 271. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 272. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 273. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 274. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 275. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 276. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 277. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 278. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 279. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 280. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 281. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 282. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 283. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 284. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 285. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 286. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 287. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 288. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 289. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 290. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 291. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 292. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 293. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 294. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 295. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 296. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 297. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 299. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 300. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 301. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 302. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 303. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 304. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 305. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 306. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 307. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 308. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 309. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 310. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 311. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 312. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 313. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 314. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 315. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 316. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 317. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 318. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 319. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 320. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 321. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 322. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 323. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 324. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 325. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 326. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2017-2032 (USD MILLION)
TABLE 328. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2032 (USD MILLION)
TABLE 329. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2017-2032 (USD MILLION)
TABLE 330. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2032 (USD MILLION)
TABLE 331. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2032 (USD MILLION)
TABLE 332. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2032 (USD MILLION)
TABLE 333. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2032 (USD MILLION)
TABLE 334. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2017-2032 (USD MILLION)
TABLE 335. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2017-2032 (USD MILLION)
TABLE 336. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 337. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 338. MEXICO ANIMAL AN

Companies Mentioned

  • AdvaCare Pharma LLP
  • Ashish Life Science Private Limited
  • Bayer AG
  • Bimeda Holdings Limited
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • China Animal Husbandry Industry Co., Ltd
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group Plc
  • Elanco Animal Health Incorporated
  • Endovac Animal Health
  • Hester Biosciences Limited
  • HIPRA S.A.
  • Huvepharma EOOD
  • Indian Immunologicals Ltd
  • Inovet Group
  • Intas Animal Health
  • Kyoritsu Seiyaku Corporation
  • Lutim Pharma Pvt Ltd
  • Meiji Holdings Co., Ltd
  • Merck & Co., Inc
  • Norbrook Laboratories Limited
  • Ouro Fino Saúde Animal
  • Phibro Animal Health Corporation
  • SeQuent Scientific Ltd
  • Vetoquinol S.A.
  • Vetsfarma Ltd
  • Virbac S.A.
  • Zoetis Inc
  • Zydus Animal Health And Investments Limited

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.87 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.41 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Animal Antibiotics and Antimicrobials - Global Strategic Business Report - Product Image

Animal Antibiotics and Antimicrobials - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Animal Antibiotics and Antimicrobials Market Report 2026 - Product Image

Animal Antibiotics and Antimicrobials Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Animal Antibiotics Antimicrobials Market Report 2026 - Product Image

Animal Antibiotics Antimicrobials Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Animal Antibiotics and Antimicrobials Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Animal Antibiotics and Antimicrobials Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 178 Pages
  • Global
From
Animal Antibacterial Peptide Market - Global Forecast 2026-2032 - Product Image

Animal Antibacterial Peptide Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.